287.71
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$285.61
Aprire:
$285.8
Volume 24 ore:
1.30M
Relative Volume:
0.56
Capitalizzazione di mercato:
$154.89B
Reddito:
$34.76B
Utile/perdita netta:
$6.62B
Rapporto P/E:
23.52
EPS:
12.23
Flusso di cassa netto:
$10.61B
1 W Prestazione:
-2.05%
1M Prestazione:
-5.22%
6M Prestazione:
-5.92%
1 anno Prestazione:
-13.08%
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Confronta AMGN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
AMGN
Amgen Inc
|
287.71 | 153.76B | 34.76B | 6.62B | 10.61B | 12.23 |
![]()
LLY
Lilly Eli Co
|
732.58 | 656.17B | 53.26B | 13.80B | -50.20M | 15.30 |
![]()
JNJ
Johnson Johnson
|
177.17 | 422.54B | 90.62B | 22.66B | 18.18B | 9.35 |
![]()
ABBV
Abbvie Inc
|
210.40 | 367.30B | 58.33B | 3.73B | 18.24B | 2.10 |
![]()
NVS
Novartis Ag Adr
|
126.55 | 244.83B | 53.40B | 13.68B | 16.89B | 6.9231 |
![]()
MRK
Merck Co Inc
|
84.12 | 207.84B | 63.43B | 16.42B | 14.72B | 6.49 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-05-20 | Ripresa | Guggenheim | Neutral |
2025-04-22 | Ripresa | Cantor Fitzgerald | Neutral |
2024-12-10 | Ripresa | BofA Securities | Underperform |
2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
2024-11-14 | Iniziato | Citigroup | Neutral |
2024-10-17 | Iniziato | Bernstein | Outperform |
2024-10-14 | Downgrade | Truist | Buy → Hold |
2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
2024-03-28 | Ripresa | Raymond James | Mkt Perform |
2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2023-11-09 | Iniziato | Deutsche Bank | Hold |
2023-11-02 | Aggiornamento | Truist | Hold → Buy |
2023-10-20 | Ripresa | JP Morgan | Neutral |
2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
2023-10-11 | Ripresa | BofA Securities | Neutral |
2023-09-06 | Iniziato | HSBC Securities | Buy |
2023-04-24 | Reiterato | Oppenheimer | Outperform |
2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2023-02-13 | Reiterato | Truist | Buy |
2022-11-18 | Iniziato | Credit Suisse | Underperform |
2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
2022-02-09 | Reiterato | Barclays | Equal Weight |
2022-02-09 | Reiterato | Jefferies | Buy |
2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
2022-02-09 | Reiterato | Oppenheimer | Outperform |
2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
2021-12-06 | Iniziato | Goldman | Buy |
2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2020-12-29 | Iniziato | Daiwa Securities | Buy |
2020-10-28 | Iniziato | UBS | Neutral |
2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2020-10-12 | Aggiornamento | Truist | Hold → Buy |
2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
2020-10-09 | Downgrade | Truist | Buy → Hold |
2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
2020-04-15 | Ripresa | Guggenheim | Neutral |
2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
2020-02-27 | Iniziato | Barclays | Equal Weight |
2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
2019-12-24 | Iniziato | Raymond James | Mkt Perform |
2019-12-17 | Ripresa | Morgan Stanley | Overweight |
2019-11-12 | Iniziato | SunTrust | Buy |
2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
2019-10-17 | Ripresa | BofA/Merrill | Neutral |
2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
Rafferty Asset Management LLC Cuts Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Harvest Portfolios Group Inc. - MarketBeat
Kayne Anderson Rudnick Investment Management LLC Cuts Stake in Amgen Inc. $AMGN - MarketBeat
Samalin Investment Counsel LLC Trims Position in Amgen Inc. $AMGN - MarketBeat
Caisse DE Depot ET Placement DU Quebec Purchases 64,253 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Stock Price Expected to Rise, Piper Sandler Analyst Says - MarketBeat
Piper Sandler Lifts PT on Amgen (AMGN) to $342 From $328, Keeps an Overweight Rating - MSN
How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Is Amgen Inc. stock bottoming outLong Setup & Technical Pattern Alert System - Newser
Amgen Inc. $AMGN Shares Sold by Corebridge Financial Inc. - MarketBeat
Top chart patterns to watch in Amgen Inc.2025 Market Outlook & Fast Exit and Entry Strategy Plans - Newser
Can momentum traders help lift Amgen Inc.Portfolio Risk Report & Intraday High Probability Alerts - Newser
Should you hold or exit Amgen Inc. nowTrade Ideas & Verified Technical Signals - Newser
With 81% ownership of the shares, Amgen Inc. (NASDAQ:AMGN) is heavily dominated by institutional owners - Yahoo Finance
A Fresh Look at Amgen (AMGN) Valuation After FDA Expands Repatha’s Market Opportunity - simplywall.st
Amgen’s Strategic Position in the Biotech Sector: Pipeline Innovation and Market Leadership - AInvest
Amgen Inc. $AMGN Shares Sold by Tema Etfs LLC - MarketBeat
Amgen Inc. $AMGN Shares Sold by Trexquant Investment LP - MarketBeat
Amgen Inc. $AMGN Shares Sold by Lansforsakringar Fondforvaltning AB publ - MarketBeat
OMERS ADMINISTRATION Corp Grows Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Comerica Bank - MarketBeat
Oak Harvest Investment Services Has $10.63 Million Position in Amgen Inc. $AMGN - MarketBeat
Freedom Investment Management Inc. Reduces Holdings in Amgen Inc. $AMGN - MarketBeat
Campbell & CO Investment Adviser LLC Sells 6,789 Shares of Amgen Inc. $AMGN - MarketBeat
ICONIQ Capital LLC Purchases New Shares in Amgen Inc. $AMGN - MarketBeat
Ieq Capital LLC Raises Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Purchased by CreativeOne Wealth LLC - MarketBeat
Amgen Inc. $AMGN Shares Sold by Quantitative Investment Management LLC - MarketBeat
MetLife Investment Management LLC Reduces Holdings in Amgen Inc. $AMGN - MarketBeat
Has Amgen Inc. found a price floorJuly 2025 Short Interest & Fast Moving Stock Watchlists - Newser
Stock Analysis | Amgen OutlookMixed Signals Amid Fundamental Strength and Volatile Technicals - AInvest
Amgen Inc. $AMGN Shares Sold by Synovus Financial Corp - MarketBeat
Pattern recognition hints at Amgen Inc. upsideJuly 2025 Big Picture & Growth-Oriented Investment Plans - Newser
Published on: 2025-08-29 17:55:21 - Newser
Does Amgen Inc. show high probability of reboundMarket Risk Report & Reliable Volume Spike Alerts - Newser
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):